This inventor holds 2 USPTO granted patents. Top assignees: Abbvie Deutschland Gmbh & Co. Kg, Disc Medicine, Inc.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Bernhard Mueller - Innovator in Myelofibrosis Treatment
Introduction
Bernhard Mueller is a notable inventor recognized for his contributions to medical science, particularly in the treatment of myelofibrosis. He has developed innovative solutions that aim to improve patient outcomes in this challenging condition.
Latest Patents
Bernhard Mueller holds a patent for "Anti-Hemojuvelin (HJV) Antibodies for Treating Myelofibrosis." This patent represents a significant advancement in therapeutic options for patients suffering from this disease. He has 1 patent to his name, showcasing his commitment to innovation in the medical field.
Career Highlights
Bernhard is currently employed at AbbVie Deutschland GmbH & Co. KG, where he continues to work on groundbreaking research and development projects. His role at AbbVie allows him to collaborate with other experts in the field and contribute to the advancement of medical treatments.
Collaborations
Throughout his career, Bernhard has worked alongside talented colleagues, including Maria Beconi and Brian MacDonald. These collaborations have fostered a creative environment that encourages the development of new ideas and solutions.
Conclusion
Bernhard Mueller's work in the field of myelofibrosis treatment exemplifies the impact of innovation in medicine. His dedication to research and development continues to pave the way for new therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile